Colfax Corp. (CFX) Announces Philip Okala to Board

Colfax Corporation (CFX) PT Raised to $53 at Northcoast Research

Northcoast Research analyst Tom Hayes raised the price target on Colfax Corporation (NYSE: CFX) to $53.00 (from $43.00) while maintaining a Buy rating.... More

Colfax Corporation (CFX) PT Raised to $41 at Citi

Citi analyst Andrew Kaplowitz raised the price target on Colfax Corporation (NYSE: CFX) to $41.00 (from $35.00) while maintaining a Sell rating.... More

Colfax Corporation (CFX) PT Raised to $55 at JPMorgan, Following Earnings

JPMorgan analyst C. Stephen Tusa Jr. raised the price target on Colfax Corporation (NYSE: CFX) to $55.00 (from $52.00) while maintaining a Overweight rating.

Colfax Corporation (CFX) PT Raised to $46 at UBS

UBS analyst Chris Snyder raised the price target on Colfax Corporation (NYSE: CFX) to $46.00 (from $45.00) while maintaining a Buy rating.... More

Colfax Corporation (CFX) PT Raised to $41 at Deutsche Bank

Deutsche Bank analyst Nicole DeBlase raised the price target on Colfax Corporation (NYSE: CFX) to $41.00 (from $38.00) while maintaining a Hold rating.... More

Colfax Corporation (CFX) PT Raised to $52 at Stifel

Stifel analyst Nathan Jones raised the price target on Colfax Corporation (NYSE: CFX) to $52.00 (from $50.00) while maintaining a Buy rating.... More

Colfax Corporation (CFX) PT Raised to $53 at BofA Securities

BofA Securities analyst Andrew Obin raised the price target on Colfax Corporation (NYSE: CFX) to $53.00 (from $50.00) while maintaining a Buy rating.... More

Colfax Corporation (CFX) PT Raised to $47 at KeyBanc

KeyBanc analyst Jeffrey Hammond raised the price target on Colfax Corporation (NYSE: CFX) to $47.00 (from $44.00) while maintaining a Overweight rating.... More

Colfax Corporation (CFX) PT Raised to $40 at Barclays

Barclays analyst Julian Mitchell raised the price target on Colfax Corporation (NYSE: CFX) to $40.00 (from $35.00) while maintaining a Equalweight rating.... More

Colfax Corporation (CFX) PT Raised to $46 at UBS

UBS analyst Chris Snyder raised the price target on Colfax Corporation (NYSE: CFX) to $46.00 (from $45.00) while maintaining a Neutral rating.... More

Colfax Corporation (CFX) PT Raised to $42 at Morgan Stanley

Morgan Stanley analyst Joshua Pokrzywinski raised the price target on Colfax Corporation (NYSE: CFX) to $42.00 (from $39.00) while maintaining a Equalweight rating.... More

UPDATE: Colfax Corp. (CFX) Tops Q4 EPS by 1c, Revenues Miss; Offers FY21 EPS Mid-Point Guidance Above Consensus, 1Q EPS Views Below Consensus

(Updated - February 18, 2021 6:12 AM EST)

Colfax Corp. (NYSE: CFX) reported Q4 EPS of $0.51, $0.01 better than the analyst estimate of $0.50. Revenue for the quarter came in at $828.12 million versus the consensus estimate of $830.72 million.

Our strong revenue, earnings and cash flow performance demonstrates further recovery in our markets and effective operating execution, said Matt Trerotola, Colfax President and CEO. Customer demand in our Fabrication Technology business strengthened at a faster pace than expected, contributing to strong sales and profit performance. Sales in our MedTech business started the quarter as expected and showed... More